Market revenue in 2023 | USD 20,594.8 million |
Market revenue in 2030 | USD 47,180.3 million |
Growth rate | 12.6% (CAGR from 2023 to 2030) |
Largest segment | Contract manufacturing |
Fastest growing segment | Contract Manufacturing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Contract Development, Contract Manufacturing |
Key market players worldwide | Catalent Inc, Lonza Group Ltd, Recipharm, Siegfried Holding AG, Thermo Fisher Scientific Inc, Labcorp Drug Development, Jabil Inc, Syngene, IQVIA Holdings Inc, Almac Group, Ajinomoto Co Inc, Alcami, Vetter Pharma-Fertigung |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to healthcare contract development and manufacturing organization market will help companies and investors design strategic landscapes.
Contract manufacturing was the largest segment with a revenue share of 77.99% in 2023. Horizon Databook has segmented the China healthcare contract development and manufacturing organization market based on contract development, contract manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
China is one of the more technologically advanced countries in Asia Pacific and contributes significantly to the region’s healthcare industry. Its growing geriatric population and the presence of a large middle income group are likely to boost the demand for innovative and cost-effective medical equipment, attracting major medical device companies to the country.
China held the largest share in Asia Pacific’s healthcare CDMO market in 2019, owing to the increase in the number of collaborations between industry players and OEMs in the country. OEMs in China tend to focus on leveraging services that help reduce product recalls and minimize time taken for regulatory approvals.
Horizon Databook provides a detailed overview of country-level data and insights on the China healthcare contract development and manufacturing organization market , including forecasts for subscribers. This country databook contains high-level insights into China healthcare contract development and manufacturing organization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account